{"title":"参议院拖延修改加拿大发展中国家可负担的仿制药法律的细节法案。","authors":"Lindsey Amèrica-Simms, Richard Elliott","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>On 26 March 2011, when Parliament was dissolved for a federal election, Bill C-393 died on the Order Paper. The bill addressed flaws in Canada's Access to Medicines Regime (CAMR), which is supposed to facilitate the export of lower-cost medications, including HIV treatments, to developing countries.</p>","PeriodicalId":87184,"journal":{"name":"HIV/AIDS policy & law review","volume":"15 3","pages":"24-6"},"PeriodicalIF":0.0000,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Senate stalling derails bill to fix Canada's law on affordable generic medicines for developing countries.\",\"authors\":\"Lindsey Amèrica-Simms, Richard Elliott\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>On 26 March 2011, when Parliament was dissolved for a federal election, Bill C-393 died on the Order Paper. The bill addressed flaws in Canada's Access to Medicines Regime (CAMR), which is supposed to facilitate the export of lower-cost medications, including HIV treatments, to developing countries.</p>\",\"PeriodicalId\":87184,\"journal\":{\"name\":\"HIV/AIDS policy & law review\",\"volume\":\"15 3\",\"pages\":\"24-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HIV/AIDS policy & law review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV/AIDS policy & law review","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Senate stalling derails bill to fix Canada's law on affordable generic medicines for developing countries.
On 26 March 2011, when Parliament was dissolved for a federal election, Bill C-393 died on the Order Paper. The bill addressed flaws in Canada's Access to Medicines Regime (CAMR), which is supposed to facilitate the export of lower-cost medications, including HIV treatments, to developing countries.